Rocket Pharmaceuticals Inc (RCKT) 財務データ
*すべての数値は百万単位です
| 期間終了日 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues | - | - | - | - | - |
3.28%46.92 | 48.51 | 43.96 | 52.25 | 71.15 | |
| Research and Development | 6.22%29.50 | 31.45 | 29.35 | 34.07 | 42.66 |
| Interest Income/Expense | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 |
| Operating Income/Loss | 3.28%-46.92 | -48.51 | -43.96 | -52.25 | -71.15 |
| Income/Loss From Continuing Operations Before Tax | 131.84 | - | -42.54 | -50.33 | -68.92 |
| Income Tax Expense/Benefit | 8.62 | - | - | - | - |
358.89%123.21 | -47.59 | -42.54 | -50.33 | -68.92 | |
| Attributable To Parent | 358.89%123.21 | -47.59 | -42.54 | -50.33 | -68.92 |
| Available To Common Stockholders, Basic | 358.89%123.21 | -47.59 | -42.54 | -50.33 | -68.92 |
| Basic Average Shares | 0.63%112.84 | 112.13 | 0.22 | 111.57 | 111.02 |
| Diluted Average Shares | 2.12%114.51 | 112.13 | 0.22 | 111.57 | 111.02 |
| Basic Earnings Per Share | 359.52%1.09 | -0.42 | -0.38 | -0.45 | -0.62 |
| Diluted Earnings Per Share | 357.14%1.08 | -0.42 | -0.38 | -0.45 | -0.62 |